{"title": "Thousands of breast cancer gene variants engineered and analyzed", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Thousands of breast cancer gene variants engineered and analyzed"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/09/180912133458.htm"}], "link": "https://www.sciencedaily.com/releases/2018/09/180912133458.htm", "summary": "A scientific analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk. Many people obtaining genetic screenings previoulsy have learned that their BRCA1 gene contains a variant of uncertain significance. Data from this study now categorizes thousands of variants as behaving like disease mutations or not, providing new information important for medical care decisions.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "A scientific analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk. Many people obtaining genetic screenings previoulsy have learned that their BRCA1 gene contains a variant of uncertain significance. Data from this study now categorizes thousands of variants as behaving like disease mutations or not, providing new information important for medical care decisions."}, "media_thumbnail": [{"url": "https://www.sciencedaily.com/images/2018/09/180912133458-large.jpg", "height": "225", "width": "300"}], "href": "", "published": "Wed, 12 Sep 2018 13:34:58 EDT", "published_parsed": [2018, 9, 12, 17, 34, 58, 2, 255, 0], "id": "https://www.sciencedaily.com/releases/2018/09/180912133458.htm", "guidislink": false}